(Q35206358)

7 August 2017

1 reference

title

Immunostimulatory CpG oligodeoxynucleotides and antibody therapy of cancer (English)

1 reference

7 August 2017

George J Weiner

2

1 reference

ORCID Public Data File 2021

author name string

Bernd Jahrsdörfer

series ordinal

1

1 reference

7 August 2017

language of work or name

1 reference

1 August 2003

1 reference

7 August 2017

1 reference

7 August 2017

volume

30

1 reference

7 August 2017

issue

4

1 reference

7 August 2017

page(s)

476-482

1 reference

A Toll-like receptor recognizes bacterial DNA

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900236-7

7 January 2021

Combined dendritic cell- and CpG oligonucleotide-based immune therapy cures large murine tumors that resist chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900236-7

7 January 2021

Peritumoral CpG DNA elicits a coordinated response of CD8 T cells and innate effectors to cure established tumors in a murine colon carcinoma model.

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900236-7

7 January 2021

Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900236-7

7 January 2021

Vaccination with tumor peptide in CpG adjuvant protects via IFN-gamma-dependent CD4 cell immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900236-7

7 January 2021

Influence of backbone chemistry on immune activation by synthetic oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900236-7

7 January 2021

Immunostimulatory DNA: sequence-dependent production of potentially harmful or useful cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900236-7

7 January 2021

CpG DNA: a pathogenic factor in systemic lupus erythematosus?

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900236-7

7 January 2021

Bacterial DNA-induced NK cell IFN-gamma production is dependent on macrophage secretion of IL-12

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900236-7

7 January 2021

Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-alpha-mediated shock

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900236-7

7 January 2021

Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900236-7

7 January 2021

CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900236-7

7 January 2021

CpG motifs in bacterial DNA and their immune effects

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900236-7

7 January 2021

Toll-like receptor 9, CpG DNA and innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900236-7

7 January 2021

Novel adjuvant systems

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900236-7

7 January 2021

Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900236-7

7 January 2021

CpG oligodeoxynucleotides enhance monoclonal antibody therapy of a murine lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900236-7

7 January 2021

Immunostimulatory CpG-oligonucleotides induce functional high affinity IL-2 receptors on B-CLL cells: costimulation with IL-2 results in a highly immunogenic phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900236-7

7 January 2021

Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900236-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900236-7

1 reference

7 January 2021

Divergent therapeutic and immunologic effects of oligodeoxynucleotides with distinct CpG motifs.

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900236-7

7 January 2021

Synthetic unmethylated cytosine-phosphate-guanosine oligodeoxynucleotides are potent stimulators of antileukemia responses in naive and bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900236-7

7 January 2021

Absence of the CD1 molecule up-regulates antitumor activity induced by CpG oligodeoxynucleotides in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900236-7

7 January 2021

NK- and CD8(+) T cell-mediated eradication of established tumors by peritumoral injection of CpG-containing oligodeoxynucleotides.

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900236-7

7 January 2021

Effective adjuvants for the induction of antigen-specific delayed-type hypersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900236-7

7 January 2021

Clinical trials of idiotype-specific vaccine in B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900236-7

7 January 2021

Effect of cell wall skeleton and monophosphoryl lipid A adjuvant on the immunogenicity of a murine B16 melanoma vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900236-7

7 January 2021

Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900236-7

7 January 2021

Repeated administration of cytosine-phosphorothiolated guanine-containing oligonucleotides together with peptide/protein immunization results in enhanced CTL responses with anti-tumor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900236-7

7 January 2021

Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900236-7

7 January 2021

Oligodeoxynucleotide modifications determine the magnitude of B cell stimulation by CpG motifs

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2803%2900236-7

7 January 2021

10.1016/S0093-7754(03)00236-7

Identifiers

DOI

1 reference

7 August 2017

1 reference